Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA

BACKGROUND: Patients with Crohn’s disease (CD) may develop fibrostenotic strictures. No currently available therapies prevent or treat fibrostenotic CD (FCD), making this a critical unmet need. AIM: To compare health outcomes and resource utilisation between CD patients with and without fibrostenoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghan, Melody, Wong, Gabriel, Neuberger, Edward, Kin, Cindy, Rieder, Florian, Park, K T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689124/
https://www.ncbi.nlm.nih.gov/pubmed/34930755
http://dx.doi.org/10.1136/bmjgast-2021-000781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689124/
https://www.ncbi.nlm.nih.gov/pubmed/34930755
http://dx.doi.org/10.1136/bmjgast-2021-000781

Ejemplares similares